Stay updated on Pembrolizumab with CyBorD in NDMM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with CyBorD in NDMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with CyBorD in NDMM Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.3%
    Check dated 2024-06-13T21:02:33.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the medical or healthcare-related publication or documentation content.
    Difference
    0.3%
    Check dated 2024-06-06T14:27:59.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of versions of the study record for the clinical trial involving Pembrolizumab and the standard first-line therapy for NDMM NTE. This change reflects the addition of a new version of the study record, which may include updated information or modifications to the study details.
    Difference
    0.3%
    Check dated 2024-05-22T21:01:39.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:42:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with CyBorD in NDMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with CyBorD in NDMM Clinical Trial page.